1Allen LaPointe NM,Zhou Y,Stafford JA. Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease[J].American Journal of Cardiology,2009,(11):1518-1524.
2Kolesnyk I,Struijk DG,Dekker FW. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease[J].Netherlands Journal of Medicine,2010,(01):15-23.
3Matsumoto S,Shimodozono M,Miyata R. Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients[J].Brain Injury,2009,(13/14):1065-1072.